News
September 02, 2025
Empowering Pharmacists in the Management of Patients With Urothelial Cancer
Sherry Vogt, PharmD, BCOP; and Megan Hinkley, PharmD, MBA, BCOP, discuss how pharmacists play a crucial role in managing patients with bladder cancer through treatment selection, patient education, adverse effect monitoring, and the evolving landscape of therapies including traditional chemotherapy, immunotherapy, and antibody-drug conjugates like enfortumab vedotin plus pembrolizumab.
**Pharmacists Step Up as Key Players in Bladder Cancer Care**
Pharmacists are increasingly recognized as vital members of the healthcare team, particularly when it comes to managing patients battling urothelial cancer, commonly known as bladder cancer. Experts Sherry Vogt, PharmD, BCOP, and Megan Hinkley, PharmD, MBA, BCOP, emphasize the expanding role pharmacists play in navigating the complexities of this disease and ensuring optimal patient outcomes.
The treatment of bladder cancer has evolved significantly in recent years, moving beyond traditional chemotherapy to include immunotherapies and innovative antibody-drug conjugates. This expanding landscape requires specialized knowledge, and pharmacists are well-equipped to provide crucial support in several key areas.
One critical aspect is treatment selection. Pharmacists possess in-depth knowledge of the various medications available, including their mechanisms of action, potential interactions, and appropriate dosages. They can collaborate with oncologists to determine the most suitable treatment plan for each individual patient, considering factors such as disease stage, overall health, and potential side effects.
Patient education is another area where pharmacists make a significant impact. Understanding the prescribed medications, potential side effects, and strategies for managing them can greatly improve a patient's adherence to treatment and overall quality of life. Pharmacists can provide clear and concise explanations, addressing any concerns and empowering patients to actively participate in their care.
Furthermore, pharmacists play a crucial role in monitoring for and managing adverse effects. Cancer treatments, while effective, can often cause a range of side effects that can be debilitating. Pharmacists are trained to identify these side effects early, recommend appropriate interventions, and adjust medication regimens as needed to minimize discomfort and ensure patient safety.
The recent introduction of antibody-drug conjugates, such as enfortumab vedotin in combination with pembrolizumab, represents a significant advancement in bladder cancer treatment. These novel therapies require careful management due to their unique mechanisms and potential toxicities. Pharmacists are at the forefront of understanding and implementing these new treatment strategies, ensuring patients receive the maximum benefit while minimizing risks.
In essence, pharmacists are becoming indispensable partners in the fight against bladder cancer, providing expertise in medication management, patient education, and adverse effect monitoring. Their contributions are helping to improve patient outcomes and enhance the overall quality of care for individuals facing this challenging disease.
Pharmacists are increasingly recognized as vital members of the healthcare team, particularly when it comes to managing patients battling urothelial cancer, commonly known as bladder cancer. Experts Sherry Vogt, PharmD, BCOP, and Megan Hinkley, PharmD, MBA, BCOP, emphasize the expanding role pharmacists play in navigating the complexities of this disease and ensuring optimal patient outcomes.
The treatment of bladder cancer has evolved significantly in recent years, moving beyond traditional chemotherapy to include immunotherapies and innovative antibody-drug conjugates. This expanding landscape requires specialized knowledge, and pharmacists are well-equipped to provide crucial support in several key areas.
One critical aspect is treatment selection. Pharmacists possess in-depth knowledge of the various medications available, including their mechanisms of action, potential interactions, and appropriate dosages. They can collaborate with oncologists to determine the most suitable treatment plan for each individual patient, considering factors such as disease stage, overall health, and potential side effects.
Patient education is another area where pharmacists make a significant impact. Understanding the prescribed medications, potential side effects, and strategies for managing them can greatly improve a patient's adherence to treatment and overall quality of life. Pharmacists can provide clear and concise explanations, addressing any concerns and empowering patients to actively participate in their care.
Furthermore, pharmacists play a crucial role in monitoring for and managing adverse effects. Cancer treatments, while effective, can often cause a range of side effects that can be debilitating. Pharmacists are trained to identify these side effects early, recommend appropriate interventions, and adjust medication regimens as needed to minimize discomfort and ensure patient safety.
The recent introduction of antibody-drug conjugates, such as enfortumab vedotin in combination with pembrolizumab, represents a significant advancement in bladder cancer treatment. These novel therapies require careful management due to their unique mechanisms and potential toxicities. Pharmacists are at the forefront of understanding and implementing these new treatment strategies, ensuring patients receive the maximum benefit while minimizing risks.
In essence, pharmacists are becoming indispensable partners in the fight against bladder cancer, providing expertise in medication management, patient education, and adverse effect monitoring. Their contributions are helping to improve patient outcomes and enhance the overall quality of care for individuals facing this challenging disease.
Category:
Politics